UK markets open in 7 hours 10 minutes
NIKKEI 225
38,923.03 +435.13 (+1.13%) HANG SENG
18,403.04 +323.43 (+1.79%) CRUDE OIL
74.07 -0.15 (-0.20%) GOLD FUTURES
2,371.00 +1.70 (+0.07%) DOW
38,571.03 -115.29 (-0.30%) Bitcoin GBP
53,684.75 +763.22 (+1.44%)
Futura Medical PLC (GYX.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
At close: 10:18AM CEST
| Previous close | 0.4200 |
| Open | 0.4180 |
| Bid | 0.4200 x 2000000 |
| Ask | 0.4540 x 2000000 |
| Day's range | 0.4180 - 0.4180 |
| 52-week range | 0.2640 - 0.7700 |
| Volume | |
| Avg. volume | 329 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
US FDA Grants for Over-the-Counter Marketing Authorization to Futura for Fast-Acting Topical Gel, MED3000, to Treat Erectile Dysfunction
GUILDFORD, England, June 12, 2023--Futura Medical plc (AIM: FUM) ("Futura" or the "Company"), a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys® drug delivery technology currently focused on sexual health, today announces that the US Food and Drug Administration ("FDA") has granted over the counter sale ("OTC") Marketing Authorisation for MED3000, the Company’s breakthrough, topical gel formulation for the treatment of erectile
© 2024 Yahoo. All rights reserved.